Edition:
United Kingdom

Aurora Cannabis Inc (ACB.TO)

ACB.TO on Toronto Stock Exchange

8.74CAD
13 Nov 2018
Change (% chg)

-- (--)
Prev Close
$8.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
27,206,223
52-wk High
$16.24
52-wk Low
$5.00

Summary

Name Age Since Current Position

Michael Singer

2016 Chairman of the Board

Steve Dobler

President, Director

Terry Booth

2014 Chief Executive Officer, Director

Glen Ibbott

2017 Chief Financial Officer

Allan Cleiren

2017 Chief Operational Officer

Debra Wilson

2018 Chief Human Resource Officer

Darren Karasiuk

2018 Executive Vice President - Adult Usage

Jillian Swainson

2018 Senior Vice President, General Counsel

Andre Jerome

2018 Senior Vice President - Business Integration

Nilda Rivera

2017 Vice President - Finance, Corporate Secretary

Dieter MacPherson

2017 Vice President - Production

Kelly Narine

2018 Vice President - Research

Nick Whitehead

2017 Vice President - Market Development

Cameron Battley

2018 Chief Corporate Officer

Neil Belot

2017 Chief Global Business Development Officer

Norma Beauchamp

2018 Director

Ronald Funk

2018 Director

Diane Jang

2017 Director

Jason Dyck

2015 Independent Director

Adam Szweras

2015 Independent Director

Marc Lakmaaker

2018 VP, Investor Relations

Biographies

Name Description

Michael Singer

Mr. Michael Singer is Chairman of the Board of the Company. He has Chartered Professional Accountant (CPA, CGA), Consultant and Entrepreneur; CFO of Clementia Pharmaceuticals Inc. since May 2015; CFO of Bedrocan Cannabis Corp. from May 2014 to June 2015; and CFO of Thallion Pharmaceuticals Inc. from March 2007 to August 2013.

Steve Dobler

Mr. Steve Dobler is President, Director of the Company. He is Professional Engineer; Vice President and part owner of Superior Safety Codes Inc.; President of ICC Enterprises Corp. since May 2002.

Terry Booth

Mr. Terry Booth is Chief Executive Officer, Director of the Company. He was President and part owner of Superior Safety Codes Inc.

Glen Ibbott

Mr. Glen Ibbott is a Chief Financial Officer of the Company. He is a seasoned senior health care executive with over 20 years of experience providing financial leadership to various public entities, including management of Canadian and international capital market strategies, mergers and acquisitions, and tax and finance, predominantly within the life sciences sector. An innovative, decisive and insightful professional, he has excelled in delivering revenue and profitability growth, both domestically and internationally, strategy execution and shareholder value creation, including key contributions to numerous corporate transactions. Most recently, Mr. Ibbott was CFO at QLT Inc, a Nasdaq Stock Market- and Toronto Stock Exchange-listed biopharmaceutical company, and played a key role in QLT's $500-million merger with Aegerion Pharmaceuticals to form Novelion Therapeutics. Prior to his time at QLT, Mr. Ibbott held various senior finance positions, including with globally operating companies such as Nordion, International Forest Products, Angiotech Pharmaceuticals, Aspreva Pharmaceuticals and Inex Pharmaceuticals. Earlier in his career, he worked within the technology practice of KPMG. Mr. Ibbott completed MBAs at Cornell University and at Queen's University, is a Canadian chartered professional accountant (CPA, CA), as well as a U.S. CPA, and holds a bachelor of business administration from Simon Fraser University.

Allan Cleiren

Mr. Allan Cleiren is Chief Operational Officer of the Company. He has nearly three decades of leadership experience in finance and operations management with both privately and publicly held companies in the life sciences, insurance, rail, construction, oil and gas service, and other sectors. Through various senior positions, he has held responsibility for all aspects of operations, including manufacturing, logistics, human resources, IT, and marketing. As a senior financial executive, Mr. Cleiren also has considerable experience in M&A and restructuring. Throughout his career, Mr. Cleiren's focus has been on achieving operational excellence and efficiency, contributing to significant revenue and profitability growth. Most recently, Mr. Cleiren was COO with Jardine Lloyd Thompson Canada Inc. (JLT), one of the world's leading providers of insurance, reinsurance and employee benefits related advice, brokerage and associated services. Prior to joining JLT, he served as Executive Vice President and formerly CFO for Universal Rail Systems Inc, and as Senior Vice President of Operations and CFO for Afexa Life Sciences. He is a member of the Board of Directors of Universal Rail Services Inc., Metalogic Inspection Services Inc., and is Chair of the Board for the Alberta Automobile Insurance Rate Board. Mr. Cleiren is a Chartered Professional Accountant (CPA, CA), holds a Bachelor of Commerce from the University of Alberta, and has a Diploma in Management Sciences from the Grant MacEwan College in Alberta. Mr. Cleiren also holds a ICD.D designation through the Institute of Corporate Directors.

Debra Wilson

Dr. Debra Wilson is Chief Human Resource Officer of the Company. Dr. Wilson joined the Company in June, 2017 and previously served as Vice President and Senior Vice President of Human Resources. She is a seasoned leader with more than 25 years' experience in human resources, developing and practicing leading edge methods. Debra earned her PhD in industrial and organizational psychology from Capella University, and her MBA from Royal Roads University, with a concentration in Human Resource Management. Believing strongly in professional development, Debra is also an adjunct instructor for courses in Human Resource at the Northern Alberta Institute of Technology (NAIT). Prior to joining Aurora, Debra was a leader in the areas of Human Resources and Organizational Development for various organizations across several industries. Debra was Director of Human Resources for Universal Rail Systems, a specialized rail construction and maintenance company with offices across Canada. Prior to that, Debra was Vice President of Human Resources and Organizational Development at Alberta Pensions Services Corporation, Senior Director of HR and Administration for Afexa Life Sciences, Vice President of Human Resources for Maclab Enterprises Inc. and Vice President of Human Resources for Bentall Kennedy.

Darren Karasiuk

Mr. Darren Anthony Karasiuk is Executive Vice President - Adult Usage of the Company. Mr. Karasiuk joins Aurora through the acquisition of MedReleaf where he was Senior Vice-President and GM, recreational where he was responsible for MedReleaf's adult use cannabis business which included the development and introduction of the AltaVie and San Rafael '71 brands into the marketplace, as well as the stewardship of the partnership with the Woodstock Cannabis Company. Mr. Karasiuk has deep experience in highly regulated industries, including private and public healthcare, pharma, tobacco, consumer packaged goods, and energy. Prior to joining MedReleaf, Mr. Karasiuk was Vice-President, Insights and Advisory at Deloitte where he was a leader in the firm's cannabis practice, co-authoring the firm's seminal study, "Recreational Marijuana: Insights and Opportunities." Previously, Mr. Karasiuk was Vice-President, Strategy, Corporate and Public Affairs at Environics Research, where he conducted many of Canada's earliest engagements on the cannabis sector. He has also been the Canadian associate for the Marijuana Policy Group, a leading Denver-based economic and policy consulting firm which helped shape the regulated medical and recreational cannabis markets. Mr. Karasiuk holds an MA from Western University and an MBA from Kellogg-Schulich.

Jillian Swainson

Ms. Jillian L. Swainson is a Senior Vice President, General Counsel of the Company. Ms. Swainson joins Aurora from Brownlee LLP, where she was a Partner in the law firm's business practice and where she handled a variety of business law matters, including corporate, commercial, intellectual property, and securities work. In addition to her general practice of business law, over the past several years she has developed an expertise in providing general counsel and advisory services to clients within the heavily regulated and increasingly complex cannabis industry. She graduated from the University of Alberta with a Bachelor of Commerce degree in 2004, and a law degree (LL.B.) in 2007. She joined Brownlee as an articling student in 2007, and was called to the bar in 2008. Ms. Swainson is also a Registered Trade-mark Agent.

Andre Jerome

Mr. Andre Jerome is a Senior Vice President - Business Integration of the Company. Mr. Jerome, a member of the Bar of Quebec for the last 23 years, joins Aurora from H2 Biopharma Inc ("H2"), where he was CEO and co-founder. H2 is a Quebec-based, late-stage applicant for Licensed Producer status, which was acquired by Aurora in November 2017. Prior to his activities in the cannabis industry, Mr. Jerome spent over two decades in the telecoms industry. He held various senior executive positions in corporate affairs, playing an important role in acquisition integration with, among others, international telecom giant Vodafone.

Nilda Rivera

Ms. Nilda Rivera is Vice President - Finance, Corporate Secretary of the Company. She was Vice President, Finance of Aurora; Controller of Aurora from August 2015 to July 31, 2017; and CFO of Avarone Metals Inc. from June 2010 to August 2015.

Dieter MacPherson

Mr. Dieter MacPherson is Vice President - Production of the Company. He is Manager of Production at Aurora from February 2017 to July 31, 2017; General Manager at Trees Dispensary from February 2015 to January 2017; Executive Director at Victoria Cannabis Buyers Club from March 2013 to February 2015; Shift Manager at Victoria Cannabis Buyers Club from January 2012 to March 2013.

Kelly Narine

Nick Whitehead

Mr. Nick Whitehead is Vice President - Market Development of the Company. He is ; Manager of Public Affairs at Aurora from January 2016 to July 2017; Director of Organizing for Sensible BC Campaign January 2013 to January 2016; Junior Transportation Planner at McCormick-Rankin Corporation May 2012 to September 2012.

Cameron Battley

Mr. Cameron Battley serves as Chief Corporate Officer of the Company. Mr. Battley is President of Health Strategy Group Inc. from January 1998 to March 2016.

Neil Belot

Mr. Neil Belot is Chief Global Business Development Officer of the Company. He was Chief Brand Officer at Aurora from September 8, 2015 to March 20, 2017; Executive Director of Canadian Medical Cannabis Industry Association from November 2014 to September 2015; Gas Portfolio & Energy Services Manager of Housing Services Corp. from September 2012 to September 2014.

Norma Beauchamp

Ms. Norma Beauchamp is Director of the Company. She was Director of MedReleaf Corp., Board of Director, Acerus Pharma and Eve Medical; Past President and CEO, Cystic Fibrosis Canada; Past SVP Pharmaceuticals, Bayer Canada; Past VP, Global Strategic Marketing, Gynecology and Andrology, Bayer AG.

Ronald Funk

Mr. Ronald Funk is Director of the Company. He is Director of MedReleaf Corp.l and Consultant.

Diane Jang

Ms. Diane Jang is Director of the Company. Ms. Jang is Business Consultant; President, Sunrise Soya Foods Inc. (from October 2015 to December 2016; General Manager, Dairy Alternatives, Earth’s Own Food Company Inc. from May 2008 to 2015; General Manager, International, SoyaWorld Inc. from 2006 to 2008; Director of Sales, SoyaWorld Inc., from 1998 to 2006; Sales and Marketing Manager, Sunrise Soya Foods, from 1992 to 1998.

Jason Dyck

Dr. Jason R.B. Dyck, Ph.D., is Independent Director of Aurora Cannabis Inc. Mr. Dyck is a professor in the Department of Pediatrics, University of Alberta since July 1999; and VicePresident, Metabolic Modulators Research Ltd. since July 1999.

Adam Szweras

Mr. Adam K. Szweras is Independent Director of the Company. Mr. Szweras, LLB, is a partner at Fogler, Rubinoff LLP. He is currently Chairman of a merchant bank and serves as a director and/or officer and audit committee member for other publicly traded companies.

Marc Lakmaaker